Cellosaurus HyCyte TPC-1 stable cell line for hLCN2 overexpression (CVCL_F4LL)
| Cell line name | HyCyte TPC-1 stable cell line for hLCN2 overexpression |
|---|---|
| Synonyms | TPC-1 stable cell line for hLCN2 overexpression |
| Accession | CVCL_F4LL |
| Resource Identification Initiative | To cite this cell line use: HyCyte TPC-1 stable cell line for hLCN2 overexpression (RRID:CVCL_F4LL) |
| Comments | Population: Japanese. Characteristics: Transfected with pPB[Exp]-EF1A-EGFP>CAG-hLCN2[NM_005564.5]>PGK-Puro. Doubling time: 18-24 hours (Hysigen=CGSC-M27171). Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; EGFP. Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6526; LCN2. Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. |
| Sequence variations |
|
| Disease | Thyroid gland papillary carcinoma (NCIt: C4035) Differentiated thyroid carcinoma (ORDO: Orphanet_146) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_6298 (TPC-1) |
| Sex of cell | Female |
| Age at sampling | Adult |
| Category | Cancer cell line |
| Cross-references | |
| Cell line collections (Providers) | Hysigen; CGSC-M27171 |
| Entry history | |
| Entry creation | 25-Jun-2026 |
| Last entry update | 25-Jun-2026 |
| Version number | 1 |